Gurnee, IL, United States of America

Mahmood Rezazadeh Azari

This inventor holds 1 USPTO granted patent. Top assignee: Baxter International Inc.. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mahmood Rezazadeh Azari. Retrieved from https://idiyas.com/inventor/mahmood-rezazadeh-azari

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mahmood Rezazadeh Azari and Pharmaceutical-Grade Hemoglobin

Introduction

Mahmood Rezazadeh Azari is an inventor associated with Gurnee, Illinois, and Baxter International Inc. His patent work addresses the purification of pharmaceutical-grade crosslinked hemoglobin.

Latest Patents

Azari is credited with 1 patent: “Preparation of Pharmaceutical Grade Hemoglobins by Heat Treatment.” The invention describes heating a mixture of crosslinked and uncrosslinked hemoglobin in the presence of nonstoichiometric amounts of oxygen. This process selectively precipitates the uncrosslinked hemoglobin, which can then be separated from the supernatant. The remaining crosslinked hemoglobin is purified without requiring an additional chromatography step. The patent describes the resulting material as highly crosslinked, free of chromatography fines, and low in methemoglobin.

Career Highlights

Azari’s documented patent contribution focuses on a heat-treatment method for purifying hemoglobin intended for pharmaceutical use. The approach is designed to simplify purification while producing a highly purified crosslinked hemoglobin product.

Collaborations

Azari is associated with Baxter International Inc. His listed coworkers include Timothy N. Estep and August A. Ebeling.

Conclusion

Mahmood Rezazadeh Azari’s patent describes a selective heat-treatment process that supports the purification of pharmaceutical-grade crosslinked hemoglobin while avoiding a further chromatography step.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…